Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 5/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | CA3 | P07451 | 2/20 | 0.63 |
| ▸ | CA5A | P35218 | 2/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.63 |
| ▸ | CA12 | O43570 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.63 |
| ▸ | CA4 | P22748 | 1/20 | 0.63 |
| ▸ | CA6 | P23280 | 1/20 | 0.63 |
| ▸ | CA7 | P43166 | 1/20 | 0.63 |
| ▸ | CA9 | Q16790 | 1/20 | 0.63 |
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | MLYCD | O95822 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1389225 | 0.93 | EPHX1 (0.96) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL18502181 | 0.92 | EPHX1 (0.79) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL7539902 | 0.92 | CA3 (0.78) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL7716931 | 0.91 | EPHX1 (1.00) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL10688529 | 0.91 | EPHX1 (1.00) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL13010044 | 0.91 | EPHX1 (1.00) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL10690536 | 0.91 | EPHX1 (1.00) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL11475528 | 0.91 | EPHX1 (1.00) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL10683800 | 0.91 | EPHX1 (1.00) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL10685206 | 0.91 | EPHX1 (1.00) | EPHX1ALDH1A1POLBSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108516957-A | A kind of preparation method of amides compound | 湖南大学 | 2018-09-11 | — | — | CN | claimed |
| EP-4175001-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY | Mitsubishi Chemical Corporation (JP) | 2023-05-03 | — | — | EP | disclosed |
| EP-3402796-B1 | 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS | PFIZER (US) | 2020-11-18 | — | — | EP | disclosed |
| EP-3118277-B1 | METHOD FOR PRODUCING SURFACE-MODIFIED SUBSTRATE, METHOD FOR PRODUCING CONJUGATE, NOVEL HYDROSILANE COMPOUND, SURFACE TREATMENT AGENT, SURFACE TREATMENT AGENT KIT, AND SURFACE-MODIFIED SUBSTRATE | UNIV KYOTO (JP) | 2019-10-23 | — | — | EP | disclosed |
| CN-108516957-A | A kind of preparation method of amides compound | 湖南大学 | 2018-09-11 | — | — | CN | disclosed |
| US-20170247265-A1 | FILTER MEDIUM, METHOD FOR PRODUCING FILTER MEDIUM, WATER TREATMENT MODULE, AND WATER TREATMENT DEVICE | MITSUBISHI MATERIALS CORPORATION (JP) | 2017-08-31 | — | — | US | disclosed |
| EP-3207992-A1 | PHOTOCHEMICAL MODIFICATION OF A SOLID SURFACE | Micronit Microfluidics B.V. (NL) | 2017-08-23 | — | — | EP | disclosed |
| US-20170210912-A1 | HYDROPHILIC OIL REPELLENT AND PRODUCTION METHOD OF SAME, SURFACE COATING MATERIAL, COATING FILM, RESIN COMPOSITION, OIL-WATER SEPARATION FILTER MATERIAL, AND POROUS BODY | MITSUBISHI MATERIALS ELECTRONIC CHEMICALS CO., LTD. (JP) | 2017-07-27 | — | — | US | disclosed |
| WO-2017122116-A1 | 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS | PFIZER INC. (US) | 2017-07-20 | — | — | WO | disclosed |
| US-20160304970-A1 | GENE BIOMARKER TO DIAGNOSE METASTIC LIVER CANCER AND METHODS FOR TARGETING THE SAME | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2016-10-20 | — | — | US | disclosed |
| US-20070027144-A1 | Novel use of cannabinoid receptor agonist | SHIONOGI & CO., LTD. (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20040248872-A1 | Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1439169-A1 | DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-07-21 | — | — | EP | disclosed |
| US-6590123-B2 | For cancer theapy | MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY | 2003-07-08 | — | — | US | disclosed |
| US-20030027743-A1 | Tripeptidylpeptidase inhibitors | INSERM | 2003-02-06 | — | — | US | disclosed |
| US-6403561-B1 | DISORDERS ASSOCIATED WITH THE INACTIVATION OR EXCESSIVE DEGRADATION OF CHOLECYSTOKININ; INHIBITING THE ENZYMATIC HYDROLYSIS OF CHOLECYSTOKININ 1-(2(S)-AMINOBUTYRYL)-2(S)-INDOLINECARBOXYLIC ACID | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2002-06-11 | — | — | US | disclosed |
| US-6369101-B1 | Therapeutic method to treat herpes virus infection | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-04-09 | — | — | US | disclosed |
| US-20020022747-A1 | Aminobenzoic acid derivatives having anti-tumorigenic activity, methods of making and using the same | BEKESI GEORGE J (US) | 2002-02-21 | — | — | US | disclosed |
| US-6294695-B1 | HALOACETOAMIDOBENZOYLUREAS OR ETHYL HALOACETOAMIDOBENZOATES | MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK | 2001-09-25 | — | — | US | disclosed |
| WO-1997046098-A9 | CLUSTER CLEARING AGENTS | — | 1998-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027144-A1 | Novel use of cannabinoid receptor agonist | CNR2, CNR1, OPRM1 | EPHX1 982/4885ALDH1A1 2784/4885POLB 1324/4885 |
| US-20020022747-A1 | Aminobenzoic acid derivatives having anti-tumorigenic activity, methods of making and using the same | ABAT, DDC, GABBR2 | EPHX1 754/4885ALDH1A1 100/4885POLB 535/4885 |
| US-20170210912-A1 | HYDROPHILIC OIL REPELLENT AND PRODUCTION METHOD OF SAME, SURFACE COATING MATERIAL, COATING FILM, RESIN COMPOSITION, OIL-WATER SEPARATION FILTER MATERIAL, AND POROUS BODY | FABP4, FFAR1, FFAR2 | EPHX1 173/4885ALDH1A1 3491/4885POLB 3500/4885 |
| US-20040248872-A1 | Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor | DDT, WEE1, NOTUM | EPHX1 1855/4885ALDH1A1 875/4885POLB 3681/4885 |
| US-20030027743-A1 | Tripeptidylpeptidase inhibitors | DPP4, DPP3, DPP9 | EPHX1 1097/4885ALDH1A1 630/4885POLB 3529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.